BDNF and Parkinson disease: By integrating mechanistic insights with advanced therapeutic approaches, targeting the BDNF–ERK axis offers a realistic avenue not only for slowing neurodegeneration but also for potentially restoring neuronal function and improving quality of life in patients with Alzheimer’s, Parkinson’s, and Huntington’s disease.